213 related articles for article (PubMed ID: 38772282)
41. Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder.
Dallaspezia S; Poletti S; Lorenzi C; Pirovano A; Colombo C; Benedetti F
Mol Diagn Ther; 2012 Oct; 16(5):303-9. PubMed ID: 23023733
[TBL] [Abstract][Full Text] [Related]
42. Whole blood transcriptome analysis in bipolar disorder reveals strong lithium effect.
Krebs CE; Ori APS; Vreeker A; Wu T; Cantor RM; Boks MPM; Kahn RS; Olde Loohuis LM; Ophoff RA
Psychol Med; 2020 Nov; 50(15):2575-2586. PubMed ID: 31589133
[TBL] [Abstract][Full Text] [Related]
43. Synaptotagmin-7 is a key factor for bipolar-like behavioral abnormalities in mice.
Shen W; Wang QW; Liu YN; Marchetto MC; Linker S; Lu SY; Chen Y; Liu C; Guo C; Xing Z; Shi W; Kelsoe JR; Alda M; Wang H; Zhong Y; Sui SF; Zhao M; Yang Y; Mi S; Cao L; Gage FH; Yao J
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4392-4399. PubMed ID: 32041882
[TBL] [Abstract][Full Text] [Related]
44. Impaired neural stress resistance and loss of REST in bipolar disorder.
Meyer K; Ling KH; Yeo PL; Spathopoulou A; Drake D; Choi J; Aron L; Garcia-Corral M; Ko T; Lee EA; Tam JM; Perlis RH; Church GM; Tsai LH; Yankner BA
Mol Psychiatry; 2024 Jan; 29(1):153-164. PubMed ID: 37938767
[TBL] [Abstract][Full Text] [Related]
45. Pharmacogenetics of lithium response in bipolar disorder.
McCarthy MJ; Leckband SG; Kelsoe JR
Pharmacogenomics; 2010 Oct; 11(10):1439-65. PubMed ID: 21047205
[TBL] [Abstract][Full Text] [Related]
46. Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder.
Amare AT; Thalamuthu A; Schubert KO; Fullerton JM; Ahmed M; Hartmann S; Papiol S; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hou L; Hsu YH; Shekhtman T; Adli M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Hasler R; Richard-Lepouriel H; Perroud N; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Marie-Claire C; Cervantes P; Chen HC; Chillotti C; Cichon S; Cruceanu C; Czerski PM; Dalkner N; Del Zompo M; DePaulo JR; Étain B; Jamain S; Falkai P; Forstner AJ; Frisen L; Frye MA; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Fallgatter AJ; Stegmaier S; Ethofer T; Biere S; Petrova K; Schuster C; Adorjan K; Budde M; Heilbronner M; Kalman JL; Kohshour MO; Reich-Erkelenz D; Schaupp SK; Schulte EC; Senner F; Vogl T; Anghelescu IG; Arolt V; Dannlowski U; Dietrich D; Figge C; Jäger M; Lang FU; Juckel G; Konrad C; Reimer J; Schmauß M; Schmitt A; Spitzer C; von Hagen M; Wiltfang J; Zimmermann J; Andlauer TFM; Fischer A; Bermpohl F; Ritter P; Matura S; Gryaznova A; Falkenberg I; Yildiz C; Kircher T; Schmidt J; Koch M; Gade K; Trost S; Haussleiter IS; Lambert M; Rohenkohl AC; Kraft V; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Ferensztajn-Rochowiak E; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Tortorella A; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Millischer V; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Pfennig A; Pisanu C; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Maj M; Turecki G; Vieta E; Veeh J; Witt SH; Wright A; Zandi PP; Mitchell PB; Bauer M; Alda M; Rietschel M; McMahon FJ; Schulze TG; Clark SR; Baune BT
Mol Psychiatry; 2023 Dec; 28(12):5251-5261. PubMed ID: 37433967
[TBL] [Abstract][Full Text] [Related]
47. Na⁺, K⁺-ATPase Signaling and Bipolar Disorder.
Lichtstein D; Ilani A; Rosen H; Horesh N; Singh SV; Buzaglo N; Hodes A
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087257
[TBL] [Abstract][Full Text] [Related]
48. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease.
Xu Y; Liu C; Chen S; Ye Y; Guo M; Ren Q; Liu L; Zhang H; Xu C; Zhou Q; Huang S; Chen L
Cell Signal; 2014 Aug; 26(8):1680-1689. PubMed ID: 24726895
[TBL] [Abstract][Full Text] [Related]
49. Neuronal cells from bipolar individuals are more susceptible to glutamate induced apoptosis than cells from non-bipolar subjects.
Hu M; Gao Y; El-Mallakh RS
J Affect Disord; 2021 Nov; 294():568-573. PubMed ID: 34330053
[TBL] [Abstract][Full Text] [Related]
50. From the Psychiatrist's Couch to Induced Pluripotent Stem Cells: Bipolar Disease in a Dish.
Hoffmann A; Sportelli V; Ziller M; Spengler D
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29517996
[TBL] [Abstract][Full Text] [Related]
51. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons.
Chalecka-Franaszek E; Chuang DM
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8745-50. PubMed ID: 10411946
[TBL] [Abstract][Full Text] [Related]
52. MicroRNAs, Stem Cells in Bipolar Disorder, and Lithium Therapeutic Approach.
Coradduzza D; Garroni G; Congiargiu A; Balzano F; Cruciani S; Sedda S; Nivoli A; Maioli M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142403
[TBL] [Abstract][Full Text] [Related]
53. Lithium use associated with symptom severity in comorbid bipolar disorder I and migraine.
Sekula NM; Yocum AK; Anderau S; McInnis MG; Marshall DF
Brain Behav; 2022 Jun; 12(6):e32585. PubMed ID: 35510536
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological intervention to restore connectivity deficits of neuronal networks derived from ASD patient iPSC with a TSC2 mutation.
Alsaqati M; Heine VM; Harwood AJ
Mol Autism; 2020 Oct; 11(1):80. PubMed ID: 33076974
[TBL] [Abstract][Full Text] [Related]
55. Lithium and bipolar disorder: Impacts from molecular to behavioural circadian rhythms.
Moreira J; Geoffroy PA
Chronobiol Int; 2016; 33(4):351-73. PubMed ID: 27003509
[TBL] [Abstract][Full Text] [Related]
56. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
Won E; Kim YK
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
[TBL] [Abstract][Full Text] [Related]
57. Lithium response in bipolar disorder: Genetics, genomics, and beyond.
Papiol S; Schulze TG; Heilbronner U
Neurosci Lett; 2022 Aug; 785():136786. PubMed ID: 35817312
[TBL] [Abstract][Full Text] [Related]
58. Mood Stabilizers in Psychiatric Disorders and Mechanisms Learnt from In Vitro Model Systems.
Nayak R; Rosh I; Kustanovich I; Stern S
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502224
[TBL] [Abstract][Full Text] [Related]
59. Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.
Rapoport SI
ACS Chem Neurosci; 2014 Jun; 5(6):459-67. PubMed ID: 24786695
[TBL] [Abstract][Full Text] [Related]
60. Lithium treatment and hippocampal subfields and amygdala volumes in bipolar disorder.
Hartberg CB; Jørgensen KN; Haukvik UK; Westlye LT; Melle I; Andreassen OA; Agartz I
Bipolar Disord; 2015 Aug; 17(5):496-506. PubMed ID: 25809287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
